{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:29:27Z","timestamp":1791599367890,"version":"4.3.4"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jconrel.2022.05.001","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T20:43:08Z","timestamp":1652388188000},"page":"256-269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Unmet needs in glaucoma therapy: The potential role of hydrogen sulfide and its delivery strategies"],"prefix":"10.1016","volume":"347","author":[{"given":"Susmit","family":"Mhatre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Opere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somnath","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.05.001_bb0005","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ophtha.2007.03.017","article-title":"BESs Study Group, Risk factors for incident open-angle glaucoma: the Barbados Eye Studies","volume":"115","author":"Leske","year":"2008","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00347-016-0430-6","article-title":"Role of the aging visual system in glaucoma","volume":"114","author":"Unterlauft","year":"2017","journal-title":"Ophthalmologe."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0020","doi-asserted-by":"crossref","first-page":"13762","DOI":"10.1038\/s41598-021-92971-w","article-title":"Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review","volume":"11","author":"Zhang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ajo.2012.02.024","article-title":"The Changing Face of Primary Open-Angle Glaucoma in the United States: Demographic and Geographic Changes from 2011\u20132050","volume":"154","author":"Vajaranant","year":"2012","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0030","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/archopht.122.4.532","article-title":"Eye Diseases Prevalence Research Group, Prevalence of open-angle glaucoma among adults in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/02713683.2014.968935","article-title":"Gender difference in the pathophysiology and treatment of glaucoma","volume":"40","author":"Tehrani","year":"2015","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0040","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/aje\/154.2.138","article-title":"Is open-angle glaucoma associated with early menopause? The Rotterdam Study","volume":"154","author":"Hulsman","year":"2001","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0045","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2147\/OPTH.S36712","article-title":"Topical intraocular pressure therapy effects on pregnancy","volume":"6","author":"Mendez-Hernandez","year":"2012","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4103\/0301-4738.53049","article-title":"Current concepts in the pathophysiology of glaucoma","volume":"57","author":"Agarwal","year":"2009","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0055","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","article-title":"Primary open-angle glaucoma","volume":"363","author":"Weinreb","year":"2004","journal-title":"Lancet."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0060","first-page":"774","article-title":"Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis","volume":"36","author":"Quigley","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/164_2016_24","article-title":"Glaucoma-Intraocular Pressure Reduction","volume":"242","author":"Huang","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0070","first-page":"100","article-title":"Intraocular pressure","volume":"8","author":"Murgatroyd","year":"2008","journal-title":"Contin. Educ. Anaesthesia Critical Care Pain"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0075","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/archopht.1981.03930010635009","article-title":"Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage","volume":"99","author":"Quigley","year":"1981","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0080","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The Pathophysiology and Treatment of Glaucoma: A Review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.preteyeres.2004.06.001","article-title":"The optic nerve head as a biomechanical structure: A new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage","volume":"24","author":"Burgoyne","year":"2005","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0090","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/oxfordjournals.aje.a116013","article-title":"A population-based evaluation of glaucoma screening: the Baltimore Eye Survey","volume":"134","author":"Tielsch","year":"1991","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0095","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0161-6420(94)31192-4","article-title":"Cumulative incidence of patients with disc hemorrhages in glaucoma and the effect of therapy","volume":"101","author":"Hendrickx","year":"1994","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0100","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1755-3768.1986.tb00675.x","article-title":"Prognostic factors in the development of manifest open angle glaucoma. A long-term follow-up study of hypertensive and normotensive eyes","volume":"64","author":"H\u00f8vding","year":"1986","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0105","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.120.6.714","article-title":"The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma","volume":"120","author":"Gordon","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0039-6257(05)80042-6","article-title":"Mechanisms of optic nerve damage in primary open angle glaucoma","volume":"39","author":"Fechtner","year":"1994","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1350-9462(02)00008-3","article-title":"The impact of ocular blood flow in glaucoma","volume":"21","author":"Flammer","year":"2002","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0120","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bjo.78.8.643","article-title":"Deformation of the lamina cribrosa by elevated intraocular pressure","volume":"78","author":"Yan","year":"1994","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0125","first-page":"714","article-title":"Age-related changes in trabecular meshwork cellularity","volume":"21","author":"Alvarado","year":"1981","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0130","series-title":"Preparation, characterization and toxicity evaluation of a novel sustained release delivery system for a hydrogen sulfide donor - GYY 4137, M.S","author":"Patil","year":"2016"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1194\/jlr.E003533","article-title":"Lipids and lipid metabolism in the eye","volume":"51","author":"Fliesler","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0140","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1471-4159.1992.tb08912.x","article-title":"Glutamate Release in Experimental Ischaemia of the Retina: An Approach Using Microdialysis","volume":"59","author":"Louzada-Junior","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0145","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1167\/iovs.16-21130","article-title":"Alterations of Glutamate and \u03b3-Aminobutyric Acid Expressions in Normal and Myopic Eye Development in Guinea Pigs","volume":"58","author":"Guoping","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0150","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1016\/S0042-6989(97)00047-3","article-title":"Molecular basis of glutamate toxicity in retinal ganglion cells","volume":"37","author":"Sucher","year":"1997","journal-title":"Vis. Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0155","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1749-6632.1994.tb44407.x","article-title":"Calcium and Excitotoxic Neuronal Injury","volume":"747","author":"Choi","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0160","first-page":"1618","article-title":"Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine","volume":"37","author":"Vorwerk","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0165","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1517\/14728222.2010.487065","article-title":"The role of endothelin in the pathophysiology of glaucoma","volume":"14","author":"Good","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0170","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/eye.2011.309","article-title":"Current concepts on primary open-angle glaucoma genetics: a contribution to disease pathophysiology and future treatment","volume":"26","author":"Gemenetzi","year":"2012","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0175","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10792-017-0795-9","article-title":"Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: a review of the literature","volume":"39","author":"Evangelho","year":"2019","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/2040622313511286","article-title":"Glaucoma management: relative value and place in therapy of available drug treatments","volume":"5","author":"Sambhara","year":"2014","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0185","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.ophtha.2018.04.040","article-title":"Rho kinase inhibitors as a novel treatment for glaucoma and ocular hypertension","volume":"125","author":"Tanna","year":"2018","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0190","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2165\/00002512-199914050-00006","article-title":"Prostaglandin analogues in the treatment of glaucoma","volume":"14","author":"Lind\u00e9n","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0195","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/S0039-6257(02)00309-0","article-title":"Latanoprost and Cholinergic Agonists in Combination","volume":"47","author":"Toris","year":"2002","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0200","doi-asserted-by":"crossref","first-page":"P71","DOI":"10.1016\/j.ophtha.2020.10.022","article-title":"Primary Open-Angle Glaucoma Preferred Practice Pattern\u00ae","volume":"128","author":"Gedde","year":"2021","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0205","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.preteyeres.2007.01.002","article-title":"New perspectives in aqueous humor secretion and in glaucoma: the ciliary body as a multifunctional neuroendocrine gland","volume":"26","author":"Coca-Prados","year":"2007","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/15569528209052151","article-title":"Beta blockers in ophthalmology, Journal of Toxicology","volume":"1","author":"Kenneth","year":"1982","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0215","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ophtha.2005.01.042","article-title":"Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials","volume":"112","author":"van der Valk","year":"2005","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0225","first-page":"883","article-title":"An emerging treatment option for glaucoma: Rho kinase inhibitors","volume":"8","author":"Wang","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0230","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archopht.116.5.633","article-title":"H-7 Disrupts the Actin Cytoskeleton and Increases Outflow Facility","volume":"116","author":"Tian","year":"1998","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0235","first-page":"4240","article-title":"Mediation of Calcium-Independent Contraction in Trabecular Meshwork through Protein Kinase C and Rho-A","volume":"41","author":"Thieme","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0240","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7598140","article-title":"Inhibition of Rho Kinase Induces Antioxidative Molecules and Suppresses Reactive Oxidative Species in Trabecular Meshwork Cells","volume":"2017","author":"Fujimoto","year":"2017","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0245","doi-asserted-by":"crossref","first-page":"96","DOI":"10.17116\/oftalma202013605196","article-title":"Effectiveness and safety of drug combination therapy in patients with advanced primary open-angle glaucoma","volume":"136","author":"Kosakyan","year":"2020","journal-title":"Vestn. oftalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0250","first-page":"2109","article-title":"Current perspective of neuroprotection and glaucoma","volume":"9","author":"Tian","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0255","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1034\/j.1600-0420.1999.770212.x","article-title":"The medium and long-term efficacy of primary argon laser trabeculoplasty in avoiding topical medication in open angle glaucoma","volume":"77","author":"Odberg","year":"1999","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0260","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00061198-200106000-00017","article-title":"Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva","volume":"10","author":"Broadway","year":"2001","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0265","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.ophtha.2011.05.021","article-title":"Comparison of surgical outcomes between canaloplasty and trabeculectomy at 12 months\u2019 follow-up","volume":"118","author":"Ayyala","year":"2011","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0270","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jamaophthalmol.2013.5059","article-title":"Efficacy and Safety of Trabeculectomy vs Nonpenetrating Surgical Procedures: A Systematic Review and Meta-analysis","volume":"131","author":"Rulli","year":"2013","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0275","first-page":"1","article-title":"Achievements and Limits of Current Medical Therapy of Glaucoma, Glaucoma","volume":"59","author":"Kalouda","year":"2017","journal-title":"Surgery."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0280","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s10384-020-00781-w","article-title":"Effectiveness and limitations of minimally invasive glaucoma surgery targeting Schlemm\u2019s canal","volume":"65","author":"Kasahara","year":"2021","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0285","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/ICU.0000000000000640","article-title":"Management of the glaucoma patient progressing at low normal intraocular pressure","volume":"31","author":"Wang","year":"2020","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0290","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.exer.2010.08.009","article-title":"Neuroprotection in glaucoma \u2013 Is there a future role?","volume":"91","author":"Baltmr","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100801","article-title":"Beyond intraocular pressure: Optimizing patient-reported outcomes in glaucoma","volume":"76","author":"Fenwick","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0300","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/0022-3859.917","article-title":"Neuroprotection in glaucoma","volume":"49","author":"Kaushik","year":"2003","journal-title":"J. Postgrad. Med."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0305","author":"Practice Guidelines - American Academy of Ophthalmology"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0310","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0002-9394(14)70907-9","article-title":"Adverse Side Effects Associated With Latanoprost","volume":"124","author":"Rowe","year":"1997","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0315","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3121\/cmr.2019.1486","article-title":"Neuropsychiatric Adverse Events from Topical Ophthalmic Timolol","volume":"17","author":"Cimolai","year":"2019","journal-title":"Clin. Med. Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0320","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/jvim.13931","article-title":"Effects of 0.5% Timolol Maleate Ophthalmic Solution on Heart Rate and Selected Echocardiographic Indices in Apparently Healthy Cats","volume":"30","author":"Gunther-Harrington","year":"2016","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0325","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/17512433.2021.1931123","article-title":"Oral acetazolamide for intraocular pressure lowering: balancing efficacy and safety in ophthalmic practice","volume":"14","author":"Gulati","year":"2021","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0330","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/14656566.2018.1544241","article-title":"Brimonidine tartrate for the treatment of glaucoma","volume":"20","author":"Oh","year":"2019","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0335","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.vaa.2017.06.005","article-title":"Sedative and physiological effects of brimonidine tartrate ophthalmic solution in healthy cats","volume":"44","author":"Ogata","year":"2017","journal-title":"Vet. Anaesth. Analg."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0340","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2147\/OPTH.S154001","article-title":"Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date","volume":"12","author":"Dasso","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0345","article-title":"Netarsudil-associated epithelial keratopathy","volume":"19","author":"Ramakrishnan","year":"2020","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0350","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1001\/jamaophthalmol.2016.1881","article-title":"Effect of Pilocarpine Hydrochloride on the Schlemm Canal in Healthy Eyes and Eyes With Open-Angle Glaucoma","volume":"134","author":"Skaat","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0355","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1152\/physrev.00017.2011","article-title":"Physiological implications of hydrogen sulfide: a whiff exploration that blossomed","volume":"92","author":"Wang","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0360","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jat\/13.2.105","article-title":"Determination of sulfide in brain tissue by gas dialysis\/ion chromatography: postmortem studies and two case reports","volume":"13","author":"Goodwin","year":"1989","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0365","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1523\/JNEUROSCI.16-03-01066.1996","article-title":"The possible role of hydrogen sulfide as an endogenous neuromodulator","volume":"16","author":"Abe","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0370","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrd2425","article-title":"Hydrogen sulphide and its therapeutic potential","volume":"6","author":"Szab\u00f3","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0375","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.bmcl.2009.02.007","article-title":"New prostaglandin derivative for glaucoma treatment","volume":"19","author":"Perrino","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0380","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1248\/bpb.28.65","article-title":"Potent reduction of intraocular pressure by nipradilol plus latanoprost in ocular hypertensive rabbits","volume":"28","author":"Orihashi","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0385","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/bj2690335","article-title":"Sequence of cDNA for rat cystathionine gamma-lyase and comparison of deduced amino acid sequence with related Escherichia coli enzymes","volume":"269","author":"Erickson","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0390","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1242\/jeb.200.20.2609","article-title":"Sulfide acquisition by the vent worm Riftia pachyptila appears to be via uptake of HS-, rather than H2S","volume":"200","author":"Goffredi","year":"1997","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0395","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/gut.46.1.64","article-title":"The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis","volume":"46","author":"Pitcher","year":"2000","journal-title":"Gut."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0400","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1006\/bbrc.1997.6878","article-title":"The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide","volume":"237","author":"Hosoki","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0405","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1096\/fj.06-6270fje","article-title":"Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation","volume":"20","author":"Zanardo","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0410","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3390\/molecules26092411","article-title":"Hydrogen Sulfide: Novel Endogenous and Exogenous Modulator of Oxidative Stress in Retinal Degeneration Diseases","volume":"26","author":"Li","year":"2021","journal-title":"Molecules."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0415","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1582-4934.2009.00645.x","article-title":"Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability?","volume":"13","author":"Whiteman","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0420","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1152\/japplphysiol.00793.2005","article-title":"Carbon monoxide and hydrogen sulfide: gaseous messengers in cerebrovascular circulation","volume":"100","author":"Leffler","year":"2006","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0425","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neuint.2007.05.016","article-title":"Hydrogen sulfide: neurochemistry and neurobiology","volume":"52","author":"Qu","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0430","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.freeradbiomed.2009.09.018","article-title":"Making and working with hydrogen sulfide: The chemistry and generation of hydrogen sulfide in vitro and its measurement in vivo: a review","volume":"47","author":"Hughes","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0435","doi-asserted-by":"crossref","first-page":"10628","DOI":"10.1128\/JVI.78.19.10628-10635.2004","volume":"78","author":"Moore","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0440","doi-asserted-by":"crossref","first-page":"6904327","DOI":"10.1155\/2016\/6904327","article-title":"Interaction of Hydrogen Sulfide with Nitric Oxide in the Cardiovascular System","volume":"2016","author":"Nagpure","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0445","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/ars.2008.2253","article-title":"3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain","volume":"11","author":"Shibuya","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0450","doi-asserted-by":"crossref","first-page":"12675","DOI":"10.1074\/jbc.274.18.12675","article-title":"Kinetics and Inhibition of Recombinant Human Cystathionine \u03b3-Lyase: TOWARD THE RATIONAL CONTROL OF TRANSSULFURATION*","volume":"274","author":"Steegborn","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0455","doi-asserted-by":"crossref","first-page":"21903","DOI":"10.1074\/jbc.R110.128363","article-title":"Redox biochemistry of hydrogen sulfide","volume":"285","author":"Kabil","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0460","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11064-008-9793-7","article-title":"Effect of hydrogen sulfide on sympathetic neurotransmission and catecholamine levels in isolated porcine iris-ciliary body","volume":"34","author":"Kulkarni","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0465","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.exer.2008.09.011","article-title":"Inhibitory action of hydrogen sulfide on muscarinic receptor-induced contraction of isolated porcine irides","volume":"87","author":"Monjok","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0470","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11064-009-0085-7","article-title":"Effect of hydrogen sulfide on cyclic AMP production in isolated bovine and porcine neural retinae","volume":"35","author":"Njie-Mbye","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0475","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s11064-015-1784-x","article-title":"Pharmacological Actions of Hydrogen Sulfide Donors on Sympathetic Neurotransmission in the Bovine Anterior Uvea, In Vitro","volume":"41","author":"Salvi","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0480","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/jop.2015.0144","article-title":"Effect of Hydrogen Sulfide Donors on Intraocular Pressure in Rabbits","volume":"32","author":"Salvi","year":"2016","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0485","first-page":"1609","article-title":"Changes in aqueous norepinephrine and cyclic adenosine monophosphate during the circadian cycle in rabbits","volume":"32","author":"Yoshitomi","year":"1991","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0490","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1076\/ceyr.25.2.99.10161","article-title":"Time dependent effects of sympathetic denervation on aqueous humor dynamics and choroidal blood flow in rabbits","volume":"25","author":"Zhan","year":"2002","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0495","author":"Ohia"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0500","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/jop.2016.0037","article-title":"Effects of hydrogen sulfide-releasing compounds on aqueous humor outflow facility in porcine ocular anterior segments, ex vivo","volume":"33","author":"Robinson","year":"2017","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0505","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.exer.2018.01.004","article-title":"Hydrogen sulfide supplement attenuates the apoptosis of retinal ganglion cells in experimental glaucoma","volume":"168","author":"Huang","year":"2018","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0510","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/ph13090213","article-title":"Proteomics reveals the potential protective mechanism of hydrogen sulfide on retinal ganglion cells in an ischemia\/reperfusion injury animal model","volume":"13","author":"Liu","year":"2020","journal-title":"Pharmaceuticals."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0515","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1167\/iovs.17-22200","article-title":"Hydrogen sulfide protects retinal ganglion cells against glaucomatous injury in vitro and in vivo","volume":"58","author":"Liu","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0520","first-page":"2535","article-title":"Hydrogen sulfide protects retinal ganglion cells from cell death due to elevated hydrostatic pressure in vitro","volume":"58","author":"Prokosch-Willing","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0525","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.niox.2017.04.010","article-title":"Hydrogen sulfide attenuates cardiac injury in takotsubo cardiomyopathy by alleviating oxidative stress","volume":"67","author":"Zhang","year":"2017","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0530","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1096\/fj.04-1815fje","article-title":"Hydrogen sulfide protects neurons from oxidative stress","volume":"18","author":"Kimura","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/ars.2008.2282","article-title":"Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria","volume":"12","author":"Kimura","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0540","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1007\/s11064-009-9984-x","article-title":"Regulation of [3H] D-aspartate release from mammalian isolated retinae by hydrogen sulfide","volume":"34","author":"Opere","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0545","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s11064-018-2471-5","article-title":"comparative effects of hydrogen sulfide-releasing compounds on [3H]D-aspartate release from bovine isolated retinae","volume":"43","author":"Bankhele","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0550","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/aps.2009.24","article-title":"Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases","volume":"30","author":"Dong","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0555","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bph.12163","article-title":"Treatment with hydrogen sulfide alleviates streptozotocin-induced diabetic retinopathy in rats","volume":"169","author":"Si","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0560","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.exer.2013.10.004","article-title":"Pharmacological actions of the slow release hydrogen sulfide donor GYY4137 on phenylephrine-induced tone in isolated bovine ciliary artery","volume":"116","author":"Chitnis","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0565","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1111\/bph.14024","article-title":"Principles of pharmacology in the eye","volume":"174","author":"Awwad","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0570","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejpb.2016.10.009","article-title":"Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part I - Barriers and determining factors in ocular delivery","volume":"110","author":"S\u00e1nchez-L\u00f3pez","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0575","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1124\/dmd.113.052704","article-title":"Expression of efflux transporters in human ocular tissues","volume":"41","author":"Chen","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0580","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s11095-009-9890-6","article-title":"Efflux protein expression in human retinal pigment epithelium cell lines","volume":"26","author":"Mannermaa","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0585","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.addr.2006.07.024","article-title":"Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics","volume":"58","author":"Mannermaa","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.scitotenv.2006.01.034","article-title":"Hydrogen sulfide (H2S) and sour gas effects on the eye. A historical perspective","volume":"367","author":"Lambert","year":"2006","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0595","series-title":"Handbook of Clinical Neurology","first-page":"111","article-title":"Chapter 8 - Hydrogen sulfide intoxication","author":"Guidotti","year":"2015"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0600","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/bph.12869","article-title":"Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia","volume":"172","author":"Bos","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0605","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/SHK.0b013e3181d0ee3d","article-title":"Hydrogen sulfide does not increase resuscitability in a porcine model of prolonged cardiac arrest","volume":"34","author":"Derwall","year":"2010","journal-title":"Shock."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0610","doi-asserted-by":"crossref","first-page":"H801","DOI":"10.1152\/ajpheart.00377.2008","article-title":"Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling","volume":"295","author":"Jha","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2022.05.001_bb0615","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1538-7836.2009.03364.x","article-title":"Contribution of allosteric disulfide bonds to regulation of hemostasis","volume":"7","author":"Hogg","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0620","first-page":"R297","article-title":"The therapeutic potential of hydrogen sulfide: separating hype from hope","volume":"301","author":"Olson","year":"2011","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0625","series-title":"A Novel Particle-Based In Situ Gelling System for Delivering Hydrogen Sulfide at a Sustained Rate for Potential Application in Glaucoma and Retinal Neurodegeneration, M.S.","author":"Verma","year":"2017"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0630","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/med.21433","article-title":"Toward hydrogen sulfide based therapeutics: critical drug delivery and developability issues","volume":"38","author":"Zheng","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2020.01.057","article-title":"Advances and limitations of drug delivery systems formulated as eye drops","volume":"321","author":"Jumelle","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0640","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1021\/acs.accounts.1c00506","article-title":"The path to controlled delivery of reactive sulfur species","volume":"54","author":"Ni","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0645","first-page":"47","article-title":"Ocular drug delivery systems: An overview, World","volume":"2","author":"Patel","year":"2013","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0650","first-page":"491","article-title":"The effect of pilocarpine Ocusert with different release rates on ocular pressure","volume":"12","author":"Armaly","year":"1973","journal-title":"Investig. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0655","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/archopht.1975.01010020665001","article-title":"Pilocarpine ocuserts: long-term clinical trials and selected pharmacodynamics","volume":"93","author":"Quigley","year":"1975","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0660","series-title":"Ocuserts: A Novel Formulation Approach in Drug Delivery System","author":"Parveen","year":"2020"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0665","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1755-3768.1980.tb08319.x","article-title":"Practical problems in the use of Ocusert-pilocarpine delivery system","volume":"58","author":"Sihvola","year":"1980","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0670","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/0142-9612(90)90035-O","article-title":"Physico-chemical considerations in the development of an ocular polymeric drug delivery system","volume":"11","author":"Bawa","year":"1990","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0675","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.ophtha.2016.04.026","article-title":"Collaborators, six-month intraocular pressure reduction with a topical bimatoprost ocular insert: results of a phase II randomized controlled study","volume":"123","author":"Brandt","year":"2016","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0680","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0378-5173(90)90004-N","article-title":"Modification of ocular and systemic absorption of timolol from ocular inserts by a buffering agent and a vasoconstrictor","volume":"65","author":"Finne","year":"1990","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0685","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095461","article-title":"Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluation","volume":"9","author":"Franca","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0690","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpharm.2004.11.033","article-title":"Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle","volume":"292","author":"Gulsen","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0695","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/0002-9394(77)90141-6","article-title":"A soluble sustained-release ophthalmic delivery unit","volume":"83","author":"Katz","year":"1977","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0700","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1021\/ie0507934","article-title":"Modeling ophthalmic drug delivery by soaked contact lenses","volume":"45","author":"Li","year":"2006","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0705","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s40266-020-00769-8","article-title":"Bimatoprost implant: first approval","volume":"37","author":"Shirley","year":"2020","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0710","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/jop.2018.0067","article-title":"Intracameral sustained-release bimatoprost implant delivers bimatoprost to target tissues with reduced drug exposure to off-target tissues","volume":"35","author":"Seal","year":"2019","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0715","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/bph.12806","article-title":"Pharmacological tools for hydrogen sulphide research: a brief, introductory guide for beginners","volume":"172","author":"Papapetropoulos","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0720","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-3-319-18144-8_18","article-title":"Medicinal chemistry: insights into the development of novel H2S donors","volume":"230","author":"Zhao","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0725","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.1021\/jm901638j","article-title":"Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals","volume":"53","author":"Caliendo","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0730","doi-asserted-by":"crossref","first-page":"17977","DOI":"10.1073\/pnas.0705710104","article-title":"Hydrogen sulfide mediates the vasoactivity of garlic","volume":"104","author":"Benavides","year":"2007","journal-title":"PNAS."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0735","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.bcp.2012.10.019","article-title":"Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras","volume":"85","author":"Kashfi","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0740","doi-asserted-by":"crossref","first-page":"203","DOI":"10.7555\/JBR.28.20140037","article-title":"GYY4137 protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in rats","volume":"29","author":"Meng","year":"2015","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0745","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/09537104.2013.786823","article-title":"Effect of the hydrogen sulfide donor GYY4137 on platelet activation and microvascular thrombus formation in mice","volume":"25","author":"Grambow","year":"2014","journal-title":"Platelets."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0750","doi-asserted-by":"crossref","first-page":"10924","DOI":"10.1038\/s41598-017-11256-3","article-title":"GYY4137, a hydrogen sulfide donor modulates miR194-dependent collagen realignment in diabetic kidney","volume":"7","author":"John","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0755","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3892\/ijo.2014.2305","article-title":"GYY4137, a hydrogen sulfide (H2S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway","volume":"44","author":"Lu","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0760","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/bs.mie.2014.11.014","article-title":"Chapter nine - GYY4137, a novel water-soluble, H2S-releasing molecule","author":"Rose","year":"2015"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0765","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/691070","article-title":"Hydrogen sulfide donor GYY4137 protects against myocardial fibrosis","volume":"2015","author":"Meng","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0770","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1021\/ol401118k","article-title":"Light-induced hydrogen sulfide release from \u201cCaged\u201d gem-dithiols","volume":"15","author":"Devarie-Baez","year":"2013","journal-title":"Org. Lett."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0775","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bmcl.2014.11.084","article-title":"Development of photo-controllable hydrogen sulfide donor applicable in live cells","volume":"25","author":"Fukushima","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0780","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1039\/C3CC47421F","article-title":"Synthesis of a photocontrollable hydrogen sulfide donor using ketoprofenate photocages","volume":"50","author":"Fukushima","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0785","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1002\/anie.201511244","article-title":"Esterase-sensitive prodrugs with tunable release rates and direct generation of hydrogen sulfide","volume":"55","author":"Zheng","year":"2016","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0790","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1021\/jacs.6b01373","article-title":"pH-controlled hydrogen sulfide release for myocardial ischemia-reperfusion injury","volume":"138","author":"Kang","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0795","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0378-4347(01)00046-9","article-title":"Determination of hydrogen sulfide and acid-labile sulfur in animal tissues by gas chromatography and ion chromatography","volume":"757","author":"Ubuka","year":"2001","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2019.115672","article-title":"Fluorescent probes with multiple channels for simultaneous detection of Cys, Hcy, GSH, and H2S","volume":"121","author":"Xu","year":"2019","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0805","first-page":"681","article-title":"Modified methylene blue method for measurement of hydrogen sulfide level in plasma","volume":"64","author":"Zheng","year":"2012","journal-title":"Sheng Li Xue Bao"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0810","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/bs.mie.2014.11.039","article-title":"Chapter Two - Measurement of H2S In Vivo and In Vitro by the Monobromobimane Method","author":"Shen","year":"2015"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0815","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1039\/AN9881300839","article-title":"Determination of sulphide in blood with an ion-selective electrode by pre-concentration of trapped sulphide in sodium hydroxide solution","volume":"113","author":"Lindell","year":"1988","journal-title":"Analyst."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0820","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00484-019-01823-w","article-title":"Hydrogen sulfide biosynthesis is impaired in the osteoarthritic joint","volume":"64","author":"Burguera","year":"2020","journal-title":"Int. J. Biometeorol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0825","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.niox.2018.05.008","article-title":"AMPK activation promotes gastroprotection through mutual interaction with the gaseous mediators H2S, NO, and CO","volume":"78","author":"de Ara\u00fajo","year":"2018","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0830","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00484-019-01807-w","article-title":"Effect of balneotherapy in sulfurous water on an in vivo murine model of osteoarthritis","volume":"64","author":"Vaamonde-Garc\u00eda","year":"2020","journal-title":"Int. J. Biometeorol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0835","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.vascn.2017.10.008","article-title":"The detection and quantification, in vivo and in real time, of hydrogen sulfide in ethanol-induced lesions in rat stomachs using an ion sensitive electrode","volume":"89","author":"Vel\u00e1zquez-Moyado","year":"2018","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0840","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12951-021-00784-w","article-title":"Novel controlled and targeted releasing hydrogen sulfide system exerts combinational cerebral and myocardial protection after cardiac arrest","volume":"19","author":"Sun","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0845","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.2147\/IJN.S104604","article-title":"Controlled release hydrogen sulfide delivery system based on mesoporous silica nanoparticles protects graft endothelium from ischemia-reperfusion injury","volume":"11","author":"Wang","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2021.132174","article-title":"A fluorescent probe for selective and instantaneous detection of hydrogen sulfide in living cells and zebrafish","volume":"89","author":"Niu","year":"2021","journal-title":"Tetrahedron."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0855","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1208\/s12249-014-0117-8","article-title":"In vitro-controlled release delivery system for hydrogen sulfide donor","volume":"15","author":"Ali","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0860","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1208\/s12249-017-0712-6","article-title":"Sustained-release delivery system of a slow hydrogen sulfide donor, GYY 4137, for potential application in glaucoma","volume":"18","author":"Patil","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0865","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.bmcl.2016.02.005","article-title":"Ammonium tetrathiomolybdate as a water-soluble and slow-release hydrogen sulfide donor","volume":"26","author":"Xu","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0870","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuroscience.2016.11.019","article-title":"Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model","volume":"341","author":"Huang","year":"2017","journal-title":"Neuroscience."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0875","author":"Singh"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0880","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1021\/acs.orglett.5b01962","article-title":"Diallyl trisulfide is a fast H2S donor, but diallyl disulfide is a slow one: the reaction pathways and intermediates of glutathione with polysulfides","volume":"17","author":"Liang","year":"2015","journal-title":"Org. Lett."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0885","first-page":"H2410","article-title":"The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability","volume":"302","author":"Predmore","year":"2012","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0890","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3390\/ijms18081645","article-title":"Dietary bioactive diallyl trisulfide in cancer prevention and treatment","volume":"18","author":"Puccinelli","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0895","doi-asserted-by":"crossref","first-page":"84338","DOI":"10.18632\/oncotarget.12609","article-title":"H2S-releasing nanoemulsions: a new formulation to inhibit tumor cells proliferation and improve tissue repair","volume":"7","author":"Ciocci","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114005","article-title":"Engineering macromolecular nanocarriers for local delivery of gaseous signaling molecules","volume":"179","author":"Hu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0905","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/CIRCULATIONAHA.107.753467","article-title":"Characterization of a novel, water-soluble hydrogen sulfide\u2013releasing molecule (GYY4137)","volume":"117","author":"Li","year":"2008","journal-title":"Circulation."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0910","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1248\/bpb.b17-01032","article-title":"GYY4137, an extended-release hydrogen sulfide donor, reduces NMDA-induced neuronal injury in the murine retina","volume":"41","author":"Sone","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0915","article-title":"The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0920","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1021\/ml400239a","article-title":"Arylthioamides as H2S donors: l-cysteine-activated releasing properties and vascular effects in vitro and in vivo","volume":"4","author":"Martelli","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0925","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.vph.2013.11.003","article-title":"Pharmacological characterization of the vascular effects of aryl isothiocyanates: is hydrogen sulfide the real player?","volume":"60","author":"Martelli","year":"2014","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0930","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1055\/s-0034-1368591","article-title":"Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of Brassicaceae?","volume":"80","author":"Citi","year":"2014","journal-title":"Planta Med."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0935","doi-asserted-by":"crossref","first-page":"17244","DOI":"10.3390\/ijms131217244","article-title":"Prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: a critical review","volume":"13","author":"Qandil","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0940","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1021\/ja1085723","article-title":"Cysteine-activated hydrogen sulfide (H2S) donors","volume":"133","author":"Zhao","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0945","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/cbic.201300552","article-title":"New biologically active hydrogen sulfide donors","volume":"14","author":"Roger","year":"2013","journal-title":"Chembiochem."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0950","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1021\/ma501044b","article-title":"Functionalization of methacrylate polymers with thiooximes: a robust postpolymerization modification reaction and a method for the preparation of H2S-releasing polymers","volume":"47","author":"Foster","year":"2014","journal-title":"Macromolecules."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0955","doi-asserted-by":"crossref","first-page":"13131","DOI":"10.1039\/C5CC04883D","article-title":"Peptide-based hydrogen sulphide-releasing gels","volume":"51","author":"Carter","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0960","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1016\/j.bmc.2012.02.028","article-title":"Thioglycine and L-thiovaline: biologically active H\u2082S-donors","volume":"20","author":"Zhou","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0965","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1021\/jacs.6b03780","article-title":"Self-immolative thiocarbamates provide access to triggered H2S donors and analyte replacement fluorescent probes","volume":"138","author":"Steiger","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0970","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053319","article-title":"cGMP-dependent protein kinase contributes to hydrogen sulfide-stimulated vasorelaxation","volume":"7","author":"Bucci","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0975","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/08982104.2014.881850","article-title":"Preparation, characterization and evaluation of novel elastic nano-sized niosomes (ethoniosomes) for ocular delivery of prednisolone","volume":"24","author":"Gaafar","year":"2014","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0980","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5762431","article-title":"Recent Progress on Nanostructures for Drug Delivery Applications","volume":"2016","author":"Lu","year":"2016","journal-title":"J. Nanomater."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0985","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1021\/nn4046024","article-title":"Sustained drug release in nanomedicine: a long-acting nanocarrier-based formulation for glaucoma","volume":"8","author":"Natarajan","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.05.001_bb0990","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/jcmm.13110","article-title":"Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles","volume":"21","author":"Salatin","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2022.05.001_bb0995","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2147\/IJN.S186225","article-title":"Controlled-releasing hydrogen sulfide donor based on dual-modal iron oxide nanoparticles protects myocardial tissue from ischemia\u2013reperfusion injury","volume":"14","author":"Wang","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.05.001_bb1000","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1002\/jcb.26070","article-title":"Enhanced entrapment and improved in vitro controlled release of N-acetyl cysteine in hybrid PLGA\/lecithin nanoparticles prepared using a nanoprecipitation\/self-assembly method","volume":"118","author":"Ahmaditabar","year":"2017","journal-title":"J. Cell. Biochem."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922002565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922002565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:22:48Z","timestamp":1759162968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922002565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":199,"alternative-id":["S0168365922002565"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.001","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unmet needs in glaucoma therapy: The potential role of hydrogen sulfide and its delivery strategies","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}